Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP)

NCT01587534 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Norzyme

Sponsor

National Cancer Center, Korea

Collaborators

[object Object]